author-photo

Violaine Planté-Bordeneuve

French Institute of Health and Medical Research
University of Paris

146

Papers

5853

Citations

Citation Trend

Filter By

Papers (107) Sort By

Journal Conference Others

Patisiran in patients with hATTR amyloidosis post-orthopedic liver transplant: 12-month results

2021 Journal of the Neurological Sciences
Show All
- Source
- Cite
- Save
Citations (0)
HELIOS-A: 9-month Results from the Phase 3 Study of Vutrisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy (1234)

2021 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Prevalence and prognostic value of small fiber neuropathy assessed by Sudoscan ® in transthyretin wild-type cardiac amyloidosis

2021 Archives of Cardiovascular Diseases Supplements
Show All
- Source
- Cite
- Save
Citations (0)
Early Data on Long-Term Efficacy and Safety of Inotersen in Patients With Hereditary Transthyretin Amyloidosis: A 2-Year Update From the Open-Label Extension of the NEURO-TTR Trial.

2020 European Journal of Neurology
Show All
- Source
- Cite
- Save
Citations (18)
Parkinson's disease polygenic risk score is not associated with impulse control disorders: A longitudinal study

2020 Parkinsonism & Related Disorders
Show All
- Source
- Cite
- Save
Citations (3)
Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis.

2019
Show All
- Source
- Cite
- Save
Citations (3)
Mode of death in cardiac amyloidosis

2019 Archives of Cardiovascular Diseases Supplements
Show All
- Source
- Cite
- Save
Citations (0)
An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy

2019 Expert Opinion on Pharmacotherapy
Show All
- Source
- Cite
- Save
Citations (16)
Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)

2019 European Heart Journal
Show All
- Source
- Cite
- Save
Citations (50)
A multidisciplinary and interprofessional therapeutic education program for patients suffering from amyloidosis: Amylo-PEP (Amyloidosis patient education program)

2019 Archives of Cardiovascular Diseases Supplements
Show All
- Source
- Cite
- Save
Citations (0)